Physician profile
Michael D Daubs
NPI 1275528416
$215,051.25
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92K · 2020: $118K · 2021: $4,338 · 2022: $459 · 2023: $589 · 2024: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738 · Travel and Lodging: $49.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.61 |
| Travel and Lodging | $49.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $206,261.02 | 2019-2021 | |
| Synthes Gmbh | $5,568.93 | 2019-2021 | |
| Globus Medical, INC. | $865.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $638.51 | 2019-2022 | |
| Medtronic, INC. | $459.03 | 2023-2024 | |
| Zimvie INC. | $319.21 | 2022-2023 | |
| Seaspine Orthopedics Corporation | $230.00 | 2019 | |
| Stryker Corporation | $144.92 | 2021 | |
| Goode Surgical INC | $123.13 | 2021-2022 | |
| Depuy Synthes Sales INC. | $118.93 | 2019 | |
| Bioventus LLC | $118.06 | 2019-2020 | |
| Medical Device Business Services, INC. | $77.51 | 2023 | Conduit, Spine & Trauma 3d Navigation |
| Smith+Nephew, INC. | $61.90 | 2023 | Renasys Go V2 Home, Pico |
| Lifenet Health | $45.82 | 2021-2023 | |
| Integra Lifesciences Corporation | $18.80 | 2023 | Tenoglide |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Daubs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.